Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13562418 | 0.82 | NOS2 (0.53) | CYP2D6KDM4EALDH1A1 | |
| SCHEMBL28839882 | 0.80 | CYP1A2 (0.46) | MMP2CYP1A2CYP2D6TBXAS1CYP11B1 | |
| SCHEMBL23206017 | 0.80 | L3MBTL1 (0.44) | CYP1A2CYP2D6KDM4EALDH1A1CYP11B1 | |
| SCHEMBL21241344 | 0.78 | ALDH1A1 (0.49) | CYP2A6CYP1A2CYP2D6KDM4EALDH1A1 | |
| SCHEMBL30932457 | 0.78 | UHRF1 (0.54) | CYP2A6KDM4EALDH1A1 | |
| SCHEMBL9923549 | 0.77 | NR1D1 (0.48) | CYP1A2CYP2D6KDM4EALDH1A1TBXAS1 | |
| SCHEMBL18459225 | 0.77 | CHRNB2 (0.43) | CYP1A2CYP2D6TBXAS1CHRNB2CHRNA4 | |
| SCHEMBL2129822 | 0.75 | ACHE (0.46) | KDM4ECYP11B1CYP11B2 | |
| SCHEMBL2749985 | 0.75 | CYP1A2 (0.71) | CYP2A6MMP2CYP1A2CYP2D6TBXAS1 | |
| SCHEMBL20228900 | 0.75 | MAPT (0.50) | CYP1A2CYP2D6ALDH1A1TBXAS1CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174536-A1 | NOVEL COMPOUNDS FOR DIAGNOSIS | AC IMMUNE SA (CH) | 2023-06-08 | — | — | US | disclosed |
| US-11031560-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2021-06-08 | — | — | US | disclosed |
| US-20180138422-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11031560-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | CYP2A6 723/4885MMP2 4645/4885CYP1A2 709/4885 |
| US-20230174536-A1 | NOVEL COMPOUNDS FOR DIAGNOSIS | SNCA, PARK7, SLC6A3 | CYP2A6 4404/4885MMP2 4236/4885CYP1A2 4576/4885 |
| US-20180138422-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ESR1, ETV6 | CYP2A6 723/4885MMP2 4645/4885CYP1A2 709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.